Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Sep-30-22 | Sep-05-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Sep-05-21 |
| | 10-Q | 10-K | 8-K | 10-Q | 10-Q | 10-Q | 10-K | 8-K |
| Revenues |
| Medical Device | 19.0 | 19.5 | | 17.5 | 18.5 | 16.9 | 17.4 | |
| Royalties | | 9.5 | | 8.8 | 9.8 | | 8.9 | |
| In Vitro Diagnostics | 5.9 | 6.5 | | 7.3 | 7.7 | 6.1 | 6.6 | |
| |
| EBITDA |
| Medical Device | -5.3 | -4.2 | | -5.3 | -3.5 | -1.6 | 1.4 | |
| In Vitro Diagnostics | 3.0 | 2.9 | | 3.5 | 3.8 | 3.2 | 3.4 | |
| |
| EBIT |
| Medical Device | -7.2 | -6.2 | | -7.3 | -5.6 | -3.8 | -0.8 | |
| In Vitro Diagnostics | 2.9 | 2.8 | | 3.4 | 3.7 | 3.2 | 3.4 | |
| |
| Mix |
| Medical Device | 76.3% | 75.0% | | 70.5% | 70.7% | 73.5% | 72.6% | |
| Royalties | | 36.6% | | 35.4% | 37.7% | | 37.0% | |
| In Vitro Diagnostics | 23.7% | 25.0% | | 29.5% | 29.3% | 26.5% | 27.4% | |
| |
| Growth |
| Medical Device | 12.5% | 12.1% | | 4.6% | -33.9% | 4.4% | 1.3% | |
| Royalties | | 7.2% | | 0.0% | -50.9% | | -10.1% | |
| In Vitro Diagnostics | -3.0% | -1.3% | | 2.9% | 8.0% | -0.1% | 22.6% | |
|